Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.

PURPOSE Detection of occult carcinoma in patients with breast cancer may aid the establishment of prognosis and development of new therapeutic approaches. To improve on existing methods of detection, we have developed a reverse-transcriptase polymerase chain reaction (RT-PCR) assay for keratin 19 (K19) transcripts to identify mammary carcinoma cells in the peripheral blood and bone marrow of patients with breast cancer. PATIENTS AND METHODS Peripheral-blood or bone marrow samples obtained from 34 patients with stages I to IV breast cancer and 39 control subjects without breast cancer were screened for K19 mRNA by nested primer PCR. RESULTS In reconstitution experiments, K19 RT-PCR reliably detected 10 mammary carcinoma cells in 1 million normal peripheral-blood mononuclear (PBMN) cells. Four of 19 patients with stage IV breast cancer had detectable K19 transcript in peripheral blood. Five of six patients with histologically negative bone marrow biopsies following preablative chemotherapy and before autologous bone marrow transplant (BMT) were positive by this assay. Stem-cell apheresis harvests obtained from one of these patients and three additional patients immediately before BMT were all K19-negative. K19 RT-PCR analysis of CSF from a breast cancer patient with known carcinomatous meningitis was also positive. Thirty-eight of 39 non-breast cancer patients had negative K19 RT-PCR assays. The one exception was a patient with chronic myelogenous leukemia. CONCLUSION RT-PCR of K19 is a sensitive, specific, and rapid method for detection of occult mammary carcinoma cells in the peripheral blood and bone marrow of patients with breast cancer. The presence of residual breast cancer cells in histologically normal bone marrow aspirates but not in stem-cell apheresis harvests is a frequent finding. This assay may be useful in diagnosing metastatic disease, as well as in monitoring the effectiveness of systemic therapy.

[1]  G. Bastert,et al.  Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  L. Mattano,et al.  Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. , 1992, Cancer research.

[3]  D. Weisenburger,et al.  Detection and clinical significance of minimal tumor cell contamination of peripheral stem call harvests , 1992 .

[4]  Jamel Chelly,et al.  Illegitimate transcription: Its use in the study of inherited disease , 1992, Human mutation.

[5]  D. Ginsburg,et al.  Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. , 1992, Blood.

[6]  D. Easton,et al.  Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. , 1991, European journal of cancer.

[7]  J. Gribben,et al.  Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. , 1991, The New England journal of medicine.

[8]  K. Pittman,et al.  Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction , 1991, The Lancet.

[9]  J. Ritz,et al.  Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. , 1991, Blood.

[10]  G. Merlo,et al.  Mutations in the p53 gene in primary human breast cancers. , 1991, Cancer research.

[11]  R. Bast,et al.  Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4‐hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres , 1991, Cancer.

[12]  J. Uchino,et al.  Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. , 1991, European journal of cancer.

[13]  R. Bast,et al.  Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. , 1991, Bone marrow transplantation.

[14]  J A Frank,et al.  Detection of malignant bone tumors: MR imaging vs scintigraphy. , 1990, AJR. American journal of roentgenology.

[15]  R. Bast,et al.  Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology. , 1990, American journal of clinical pathology.

[16]  J. Witte,et al.  Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  D. Weisenburger,et al.  Levels of detection of tumor cells in human bone marrow with or without prior culture. , 1990, Bone Marrow Transplantation.

[18]  D. Ginsburg,et al.  Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia , 1989 .

[19]  R. Cote,et al.  Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system. , 1989, Cancer research.

[20]  G. Sarkar,et al.  Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. , 1989, Science.

[21]  J. Concordet,et al.  Illegitimate transcription: transcription of any gene in any cell type. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Franke,et al.  Low level expression of cytokeratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. , 1988, European journal of cell biology.

[23]  M. Blumenberg,et al.  Embryonic expression of the human 40-kD keratin: evidence from a processed pseudogene sequence. , 1988, American journal of human genetics.

[24]  S. Wagenaar,et al.  Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. , 1988, Cancer research.

[25]  R. Cote,et al.  Monoclonal Antibodies Detect Occult Breast Carcinoma Metastases in the Bone Marrow of Patients with Early Stage Disease , 1988, The American journal of surgical pathology.

[26]  T. Powles,et al.  Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. , 1987, British medical journal.

[27]  S. Margel,et al.  Purging breast cancer cells in preparation for autologous bone marrow transplantation. , 1987, Bone marrow transplantation.

[28]  J. Bartek,et al.  Expression of monoclonal antibody-defined epitopes of keratin 19 in human tumours and cultured cells. , 1986, European journal of cancer & clinical oncology.

[29]  J. Bartek,et al.  PATTERNS OF EXPRESSION OF KERATIN 19 AS DETECTED WITH MONOCLONAL ANTIBODIES IN HUMAN BREAST TISSUES AND TUMOURS , 1985, International journal of cancer.

[30]  R. Moll,et al.  Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. , 1984, The American journal of pathology.

[31]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.

[32]  S. Takeda,et al.  Bone tumor imaging by scintigraphy of the skeleton, marrow reticuloendothelial system, and the proliferative tissue. , 1975, The American journal of roentgenology, radium therapy, and nuclear medicine.